222 reports of this reaction
1.4% of all ERTAPENEM SODIUM reports
#17 most reported adverse reaction
SEIZURE is the #17 most commonly reported adverse reaction for ERTAPENEM SODIUM. There are 222 FDA adverse event reports linking ERTAPENEM SODIUM to SEIZURE. This represents approximately 1.4% of all 15,826 adverse event reports for this drug.
Patients taking ERTAPENEM SODIUM who experience seizure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEIZURE is a less commonly reported adverse event for ERTAPENEM SODIUM, but still significant enough to appear in the safety profile.
In addition to seizure, the following adverse reactions have been reported for ERTAPENEM SODIUM:
The following drugs have also been linked to seizure in FDA adverse event reports:
SEIZURE has been reported as an adverse event in 222 FDA reports for ERTAPENEM SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEIZURE accounts for approximately 1.4% of all adverse event reports for ERTAPENEM SODIUM, making it a notable side effect.
If you experience seizure while taking ERTAPENEM SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.